Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for Diabetic Nephropathy
NCT02690883Phase 4Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Apr 2016
- Primary completion
- Dec 2019
- Modality
- Peptides
01
Overview
A Phase 4 trial of exenatide in diabetic nephropathy (DN), sponsored by Nanfang Hospital, Southern Medical University. Started Apr 2016; status: completed.
02
Drugs
exenatide
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02690883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02690883.